Vanc Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
619.30
295.40
2,722.80
427.50
559.70
Total Accounts Receivable
11.70
15.60
26.50
719.40
450.40
Inventories
-
-
356.30
1,056.30
211.20
Other Current Assets
-
2.50
387.10
41.10
453.00
Total Current Assets
631.00
313.50
3,492.70
2,244.30
1,674.30
Net Property, Plant & Equipment
-
30.90
47.90
31.00
89.70
Intangible Assets
170.00
476.00
-
-
1,136.10
Total Assets
801.00
820.40
3,540.60
2,275.30
2,900.20
ST Debt & Current Portion LT Debt
83.20
33.00
-
-
-
Accounts Payable
199.80
-
172.10
100.30
160.20
Other Current Liabilities
51.90
124.30
15.00
257.00
241.80
Total Current Liabilities
334.90
157.30
187.10
357.30
402.10
Long-Term Debt
29.40
-
-
-
-
Total Liabilities
364.30
157.30
187.10
357.30
402.10
Common Equity (Total)
436.70
663.10
3,353.50
1,918.00
2,498.10
Total Shareholders' Equity
436.70
663.10
3,353.50
1,918.00
2,498.10
Total Equity
436.70
663.10
3,353.50
1,918.00
2,498.10
Liabilities & Shareholders' Equity
801.00
820.40
3,540.60
2,275.30
2,900.20
About Vanc Pharmaceuticals
View Profile
